The drug targets the overgrowth of synovial cells and inflammatory components that drive tumor development and joint ...

A 19-year-old woman with a history of depression and anxiety symptoms was admitted to the hospital because of seizure, ...

Norgine, announced today the inclusion of IFINWIL® (eflornithine) on Australia's Pharmaceutical Benefits Scheme (PBS). This listing comes just 3 months after receiving registration by the Therapeutic ...

Real-world data support the effectiveness of combining platinum-based chemotherapy with PD-1 inhibitors for recurrent limited ...

Japan: A recent case study published in BMC Nephrology has highlighted a rare instance of peritoneal dialysis (PD)-associated ...

This gene normally makes alpha-1 antitrypsin, a protein produced in the liver that travels through the blood to the lungs to protect them from neutrophil elastase ... and primary ciliary dyskinesia, a ...

Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life announced today ...

The FSR Early Career Fellowship Grant is a cornerstone of FSR’s mission to fund breakthrough research, accelerate treatment advances, and ultimately find a cure for sarcoidosis. Through these ...

Mirdametinib is marketed under the brand name EZMEKLY ® in the European Union and is conditionally approved by the European Commission (EC) for the treatment of symptomatic, inoperable plexiform ...

A higher NLR and rapid NLR shift between weeks 2 and 4 was strongly associated with RILD risk in patients with HCC.

China, which provides more than 90% of the global supply of rare earth magnets, decided in early April to add several rare earth items to its export restriction list in retaliation for U.S. tariffs.